Anthropometry, CT, and DXA as predictors of GH deficiency in premenopausal women: ROC curve analysis

Journal of Applied Physiology

Volumn 106, Issue 2, 2009, Pages 418-422

  Bredella, Miriam A ^a,b   Utz, Andrea L ^a   Torriani, Martin ^a   Thomas, Bijoy ^a   Schoenfeld, David A ^a   Miller, Karen K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Yawkey 6E ^*  (United States)

Author keywords

Body composition; Computed tomography; Dual energy X ray absorptiometry; Growth hormone deficiency; Obesity; Receiver operator characteristic curve analysis; Waist circumference

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE;

ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; COMPUTER ASSISTED TOMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HUMAN EXPERIMENT; LEAN BODY WEIGHT; NORMAL HUMAN; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; WAIST CIRCUMFERENCE; BLOOD; BODY MASS; COMPARATIVE STUDY; ENDOCRINE DISEASE; ENDOCRINE SYSTEM EXAMINATION; INTRAABDOMINAL FAT; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PREDICTION AND FORECASTING; RADIOGRAPHY; REPRODUCIBILITY; SKINFOLD THICKNESS;

ABSORPTIOMETRY, PHOTON; ADIPOSITY; ADULT; ANTHROPOMETRY; BODY MASS INDEX; DIAGNOSTIC TECHNIQUES, ENDOCRINE; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INTRA-ABDOMINAL FAT; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; PREMENOPAUSE; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SKINFOLD THICKNESS; TOMOGRAPHY, X-RAY COMPUTED; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 61949335122     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.90998.2008     Document Type: Article

References (35)

1. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894: i-xii, 1-253, 2000.
2. Abate N, Burns D, Peshock RM, Garg A, Grundy SM. Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. J Lipid Res 35: 1490-1496, 1994. (Pubitemid 24251044)
3. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 366: 1059-1062, 2005. (Pubitemid 41338752)
4. Bengtsson BA, Brummer RJ, Eden S, Bosaeus I. Body composition in acromegaly. Clin Endocrinol (Oxf) 30: 121-130, 1989. (Pubitemid 19063216)
5. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L, Isaksson OG. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76: 309-317, 1993. (Pubitemid 23073047)
6. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 87: 2067-2079, 2002. (Pubitemid 34521490)
7. Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK, Silbert JE. Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 36: 172-177, 1982.
8. Bosaeus I, Johannsson G, Rosen T, Hallgren P, Tolli J, Sjostrom L, Bengtsson BA. Comparison of methods to estimate body fat in growth hormone deficient adults. Clin Endocrinol (Oxf) 44: 395-402, 1996. (Pubitemid 26141684)
9. Bulow B, Hagmar L, Mikoczy Z, Nordstrom CH, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol (Oxf) 46: 75-81, 1997. (Pubitemid 27072849)
10. Carrel AL, Allen DB. Effects of growth hormone on adipose tissue. J Pediatr Endocrinol Metab 13, Suppl 2: 1003-1009, 2000.
11. Clasey JL, Weltman A, Patrie J, Weltman JY, Pezzoli S, Bouchard C, Thorner MO, Hartman ML. Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. J Clin Endocrinol Metab 86: 3845-3852, 2001. (Pubitemid 32755987)
12. Franco C, Brandberg J, Lonn L, Andersson B, Bengtsson BA, Johannsson G. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. J Clin Endocrinol Metab 90: 1466-1474, 2005. (Pubitemid 40464006)
13. Freiberg MS, Pencina MJ, D'Agostino RB, Lanier K, Wilson PW, Vasan RS. BMI vs. waist circumference for identifying vascular risk. Obesity (Silver Spring) 16: 463-469, 2008.
14. Gerver WJ, De Bruin R, Delemarre v d Waal HA, Aldewereld B, Theunissen P, Westerterp KR. Effects of discontinuation of growth hormone treatment on body composition and metabolism. Horm Res 53: 215-220, 2000.
15. Han TS, Lean ME. Bioelectrical impedance analysis in nutritional research. Nutrition 14: 707-708, 1998.
16. Han TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311: 1401-1405, 1995.
17. Johannsson G, Marin P, Lonn L, Ottosson M, Stenlof K, Bjorntorp P, Sjostrom L, Bengtsson BA. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab 82: 727-734, 1997. (Pubitemid 27106578)
18. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 311: 158-161, 1995.
19. Lukaski HC. Methods for the assessment of human body composition: traditional and new. Am J Clin Nutr 46: 537-556, 1987.
20. Mattsson S, Thomas BJ. Development of methods for body composition studies. Phys Med Biol 51: R203-R228, 2006. (Pubitemid 43958616)
21. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51: 1106-1112, 1990. (Pubitemid 20201296)
22. Misra A, Wasir JS, Vikram NK. Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups. Nutrition 21: 969-976, 2005. (Pubitemid 41188097)
23. Molarius A, Seidell JC, Visscher TL, Hofman A. Misclassification of high-risk older subjects using waist action levels established for young and middle-aged adults - results from the Rotterdam Study. J Am Geriatr Soc 48: 1638-1645, 2000.
24. Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, Jonsson B. Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab 85: 1420-1425, 2000. (Pubitemid 32293559)
25. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, Willett WC, Manson JE. Abdominal adiposity and coronary heart disease in women. JAMA 280: 1843-1848, 1998.
26. Rossner S, Bo WJ, Hiltbrandt E, Hinson W, Karstaedt N, Santago P, Sobol WT, Crouse JR. Adipose tissue determinations in cadavers - a comparison between cross-sectional planimetry and computed tomography. Int J Obes 14: 893-902, 1990.
27. Smith SR, Lovejoy JC, Greenway F, Ryan D, deJonge L, de la Bretonne J, Volafova J, Bray GA. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 50: 425-435, 2001.
28. Snijder MB, Visser M, Dekker JM, Seidell JC, Fuerst T, Tylavsky F, Cauley J, Lang T, Nevitt M, Harris TB. The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry. Int J Obes Relat Metab Disord 26: 984-993, 2002. (Pubitemid 34756183)
29. Utz A, Yamamoto A, Sluss P, Breu J, Miller KK. Androgens may mediate a relative preservation of IGF-1 levels in overweight and obese women despite reduced growth hormone secretion. J Clin Endocrinol Metab 93: 4033-4040, 2008.
30. Utz AL, Yamamoto A, Hemphill L, Miller KK. Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women. J Clin Endocrinol Metab 93: 2507-2514, 2008.
31. Vahl N, Jorgensen JO, Jurik AG, Christiansen JS. Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. J Clin Endocrinol Metab 81: 2209-2215, 1996. (Pubitemid 26175948)
32. Vahl N, Jorgensen JO, Skjaerbaek C, Veldhuis JD, Orskov H, Christiansen JS. Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am J Physiol Endocrinol Metab 272: E1108-E1116, 1997. (Pubitemid 27293154)
33. Wahrenberg H, Hertel K, Leijonhufvud BM, Persson LG, Toft E, Arner P. Use of waist circumference to predict insulin resistance: retrospective study. BMJ 330: 1363-1364, 2005. (Pubitemid 40839563)
34. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21: 697-738, 2000.
35. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 117: 1658-1667, 2008.